PONTE VEDRA, Fla., Dec. 11, 2025 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition...
Sean McCarthy is participating in a panel at the Financing Solutions and Strategies for Life Sciences Conference in New York City
News | 10. 19. 2009
